AI或成重燃风投对生物技术兴趣的关键:PitchBook报告
AI may be the key to reigniting VC interest in biotech: PitchBook
生物技术与制药领域的最新动态
AI may be the key to reigniting VC interest in biotech: PitchBook
Novartis cuts hundreds of jobs; Novo’s dual-acting diabetes drug heading to Phase 3
Agilent Technologies (NYSE:A) Price Target Raised to $165.00 - MarketBeat
Imfinzi's latest label expansion; FDA seeks more information on BiomX's nebulizer
Agilent Technologies Stock Surges 9.3%, With A 5-Day Winning Spree - Trefis
Otsuka gains approval for first-of-its-kind treatment against rare kidney disease
Agilent Technologies: Steady As She Goes (NYSE:A) - Seeking Alpha
Electrical Spinal Imaging: A noninvasive, high-resolution approach that enables electrophysiological mapping of the human spinal cord
The details and entropy demons in a transmembrane allosteric machine
Large-scale seroepidemiology uncovers nephro-urological pathologies in people with tau autoimmunity
The host range of generalist and specialist phages in capsule-diverse Klebsiella hosts is driven by the evolvability of receptor-binding proteins
Enrichment of root-associated Streptomyces strains in response to drought is driven by diverse functional traits and does not predict beneficial effects on plant growth
Promega Fc Effector Assays: Measure Every Mechanism
FDA pushes back Ascendis' dwarfism drug decision date by three months
CMS sets 2027 Medicare prices for Wegovy, Trelegy and 13 other drugs
China's Zhongmou seeks to create a ‘one-size-fits-all’ rival to Luxturna
Cormorant eyes another $400M healthcare fund
Biohaven Therapeutics divulges new PKM2 activators
Chengdu Chipscreen Pharmaceutical describes new Mat2A inhibitors
New SIK inhibitors disclosed in Insilico Medicine patent